Frequently Asked Questions
The market is segmented based on Global Single-Cell Genome Sequencing Market, By Type (Instruments and Reagents), Technology (NGS, PCR, Q-PCR, Microarray, and MDA), Workflow (Single Cell Isolation, Sample Preparation, and Genomic Analysis), Disease Area (Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, and Others), Application (Circulating Cells, Cell Differentiation, Genomic Variation, Subpopulation Characterization, and Others), End User (Academic and Research Laboratories, Biotechnology and Biopharmaceutical Companies, Clinics and Others) – Industry Trends and Forecast to 2030.
.
The Global Single Cell Genome Sequencing Market size was valued at USD 2.00 USD Billion in 2022.
The Global Single Cell Genome Sequencing Market is projected to grow at a CAGR of 14% during the forecast period of 2023 to 2030.
The major players operating in the market include Oxford Nanopore Technologies, PacBio, Novogene Co, Mission Bio, Fluxion Biosciences, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, McKesson Corporation, Allscripts Healthcare, Siemens, F. Hoffmann La Roche , BioRad Laboratories, BGI, B.D., Danaher, Bruker, 10x Genomics, Promega Corporation.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
